McKesson Other Non-Current Liabilities decreased by 3.0% to $2.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.66B to $2.66B. Over 5 years (FY 2021 to FY 2026), Other Non-Current Liabilities shows an upward trend with a 9.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.75B | $1.56B | $1.61B | $1.54B | $1.55B | $1.54B | $1.80B | $1.81B | $2.07B | $2.20B | $2.38B | $2.61B | $2.53B | $2.71B | $2.60B | $2.66B | $2.87B | $2.75B | $2.74B | $2.66B |
| QoQ Change | — | -10.5% | +3.1% | -4.5% | +0.8% | -0.8% | +17.1% | +0.5% | +14.4% | +5.9% | +8.4% | +9.6% | -3.3% | +7.4% | -4.0% | +2.2% | +7.9% | -4.1% | -0.4% | -3.0% |
| YoY Change | — | — | — | — | -11.2% | -1.5% | +11.9% | +17.7% | +33.5% | +42.6% | +32.0% | +44.0% | +21.7% | +23.4% | +9.3% | +1.9% | +13.6% | +1.4% | +5.3% | +0.0% |